Hiller Sebastian Daniel, Baumgart Janine, Gerber Tiemo, Straub Beate Katharina, Lang Hauke
Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Visc Med. 2024 Aug;40(4):176-183. doi: 10.1159/000539671. Epub 2024 Jul 12.
Colorectal liver metastases (CRLM) infiltrating the hilar bifurcation is rarely described. We investigated the outcome of partial hepatectomy combined with resection of the hilar bifurcation.
Data collection for patients who underwent resection for CRLM at our institution was performed prospectively from January 2008 to August 2021. Follow-up ended in August 2023. Patients with and without bile duct infiltration of CRLM were analyzed retrospectively. The primary endpoints were overall (OS) and recurrence-free survival (RFS).
A total of 1,156 liver resections were screened. Out of those, 18 were combined resections of the liver and the hilar bifurcation. Bile duct infiltration of CRLM was histologically proven in 5 of 18 cases. Preoperative mild obstructive jaundice occurred in 6 of 18 patients and was treated by drainage. Out of those, only 2 had a confirmed infiltration of the hilar bifurcation by CRLM. The median recurrence-free survival (RFS) was 10 months in those patients with bile duct infiltration compared to 9 months in those with no infiltration ( = 0.503).
While CRLM is common, infiltration into the central biliary tract is rare. Tumor invasion of the biliary tree can cause jaundice, but jaundice does not necessarily mean tumor invasion. We have shown that combined resection of the liver and hilar bifurcation for CRLM is safe and infiltration of the bile duct by CRLM did not seem to have a significant effect on RFS or OS.
很少有关于浸润肝门分叉处的结直肠癌肝转移(CRLM)的描述。我们研究了肝部分切除术联合肝门分叉处切除术的疗效。
对2008年1月至2021年8月在我院接受CRLM切除术的患者进行前瞻性数据收集。随访于2023年8月结束。对有和无CRLM胆管浸润的患者进行回顾性分析。主要终点是总生存期(OS)和无复发生存期(RFS)。
共筛查了1156例肝切除术。其中,18例为肝和肝门分叉处联合切除术。18例中有5例经组织学证实CRLM存在胆管浸润。18例患者中有6例术前出现轻度梗阻性黄疸,经引流治疗。其中,只有2例经证实CRLM浸润肝门分叉处。胆管浸润患者的中位无复发生存期(RFS)为10个月,无浸润患者为9个月(P = 0.503)。
虽然CRLM很常见,但浸润中央胆道的情况很少见。肿瘤侵犯胆管可导致黄疸,但黄疸不一定意味着肿瘤侵犯。我们已经表明,CRLM的肝和肝门分叉处联合切除术是安全的,CRLM对胆管的浸润似乎对RFS或OS没有显著影响。